Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post about recent paper by Edison Xu et al. on X:
“Downstaging of HCC before liver transplantation.
Petients meeting UNOS-downstaging (DS) criteria vs. All-comers” (AC)
At 2 years from first local regional therapy: downstaging 82% vs 66%, p<0.001
In AC, Y-90 >TACE, 74% vs. 65%, p<0.001
5-year post-LT recurrence in AC 30% vs. 14%;p=0.02
5-year post-transplant survival was similar
In the era of immunotherapy?”
Authors: Edison Xu et al.
